Literature DB >> 9804878

Proteolysis of cell adhesion molecules by serine proteases: a role in long term potentiation?

K B Hoffman1, J Martinez, G Lynch.   

Abstract

Tissue plasminogen activator (tPA), a serine protease endogenous to hippocampal neurons, is shown to recognize a highly conserved sequence in the extracellular domain of cell adhesion molecules (CAMs). When added to brain homogenates, tPA generated a CAM fragment similar in size to that produced in hippocampal slices by brief periods of NMDA receptor stimulation. The serine protease inhibitor 4-(2-Aminoethyl)-benzenesulfonyl fluoride blocked the effects of tPA with an approximately 50% suppression at 250 microM. The inhibitor at this concentration had no evident effect on synaptic responses but caused long term potentiation to decay back to baseline over a 1 h period. These results suggest that extracellular breakdown of cell adhesion molecules initiated by NMDA receptors and mediated by serine proteases contributes to the formation of stable potentiation. Copyright 1998 Published by Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9804878     DOI: 10.1016/s0006-8993(98)00906-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  12 in total

Review 1.  The Role of Proteases in Hippocampal Synaptic Plasticity: Putting Together Small Pieces of a Complex Puzzle.

Authors:  Ivan L Salazar; Margarida V Caldeira; Michele Curcio; Carlos B Duarte
Journal:  Neurochem Res       Date:  2015-11-07       Impact factor: 3.996

2.  AMPA receptor stimulation increases alpha5beta1 integrin surface expression, adhesive function and signaling.

Authors:  Ching-Yi Lin; Gary Lynch; Christine M Gall
Journal:  J Neurochem       Date:  2005-07       Impact factor: 5.372

3.  Estrogen's Effects on Excitatory Synaptic Transmission Entail Integrin and TrkB Transactivation and Depend Upon β1-integrin function.

Authors:  Weisheng Wang; Svetlana Kantorovich; Alex H Babayan; Bowen Hou; Christine M Gall; Gary Lynch
Journal:  Neuropsychopharmacology       Date:  2016-06-08       Impact factor: 7.853

Review 4.  Targeting astrocyte signaling for chronic pain.

Authors:  Yong-Jing Gao; Ru-Rong Ji
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

Review 5.  Integrins as receptor targets for neurological disorders.

Authors:  Xin Wu; Doodipala Samba Reddy
Journal:  Pharmacol Ther       Date:  2011-12-30       Impact factor: 12.310

6.  Permissive proteolytic activity for visual cortical plasticity.

Authors:  Nobuko Mataga; Nobuo Nagai; Takao K Hensch
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

7.  Inhibition of matrix metalloproteinase activity disrupts reconsolidation but not consolidation of a fear memory.

Authors:  Travis E Brown; Adrianne R Wilson; Davelle L Cocking; Barbara A Sorg
Journal:  Neurobiol Learn Mem       Date:  2008-10-23       Impact factor: 2.877

8.  Gene expression of metabolic enzymes and a protease inhibitor in the prefrontal cortex are decreased in schizophrenia.

Authors:  Marquis P Vawter; Cynthia Shannon Weickert; Erick Ferran; Mitsuyuki Matsumoto; Kevin Overman; Thomas M Hyde; Daniel R Weinberger; William E Bunney; Joel E Kleinman
Journal:  Neurochem Res       Date:  2004-06       Impact factor: 3.996

9.  Matrix metalloproteinase-dependent shedding of intercellular adhesion molecule-5 occurs with long-term potentiation.

Authors:  K Conant; Y Wang; A Szklarczyk; A Dudak; M P Mattson; S T Lim
Journal:  Neuroscience       Date:  2010-01-04       Impact factor: 3.590

10.  Altered Expression of Brain Proteinase-Activated Receptor-2, Trypsin-2 and Serpin Proteinase Inhibitors in Parkinson's Disease.

Authors:  Michael J Hurley; Pascal F Durrenberger; Steve M Gentleman; Andrew F Walls; David T Dexter
Journal:  J Mol Neurosci       Date:  2015-05-17       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.